Actualités Marinus Pharmaceuticals Inc - MRNS | Actions NASDAQ | ADVFN

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Marinus Pharmaceuticals Inc (MRNS)
Marinus Pharmaceuticals Inc (MRNS) Actualités

Marinus Pharmaceuticals Inc (MRNS)

0,5411

0,0041

(0,76%)

À la fermeture: 14 Janvier 10:00PM

Retardé de 15 minutes

0,54

-0,0011

( -0,20% )

Après les heures de négociation: 12:21AM

Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Form SC TO-T - Tender offer statement by Third Party

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form SC TO-C - Written communication relating to an issuer or third party

Form SC14D9C - Written communication relating to third party tender offer

Form 8-K - Current report

Form 8-K - Current report

Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.

Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company...

Form 8-K - Current report

Form 8-K - Current report

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Marinus Pharmaceuticals

GraniteShares 5x Long MI...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales